Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
77°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aerie Pharmaceuticals
(NQ:
AERI
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 18, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
15.24 (31)
Ask (Size)
15.25 (201)
Prev. Close
15.25
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
47,233,646
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Aerie Pharmaceuticals's Return On Capital Employed Overview
November 25, 2022
Via
Benzinga
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
November 22, 2022
From
Alcon Inc. Investors
Via
Business Wire
Performance
More News
Read More
AiViva Reports That Their Promising New Treatment For Wet AMD Is Soon To Be Ready For Clinical Trials
November 14, 2022
Via
Benzinga
Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results
November 03, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
AERIE PHARMACEUTICALS - INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI
October 14, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
October 04, 2022
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year
September 19, 2022
Via
Investor's Business Daily
Aerie Pharmaceuticals to Host Key Opinion Leader Event on Dry Eye Disease: Current Landscape, Unmet Needs, and Emerging Treatment Options
September 13, 2022
From
Aerie Pharmaceuticals, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022
August 29, 2022
Via
Benzinga
AERIE PHARMACEUTICALS - INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI
August 24, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2022
August 24, 2022
Via
Benzinga
Aerie Pharmaceuticals's Return On Capital Employed Overview
August 24, 2022
Via
Benzinga
AERI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Aerie Pharmaceuticals, Inc. Is Fair to Shareholders
August 24, 2022
From
Halper Sadeh LLP
Via
Business Wire
Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday
August 24, 2022
Via
Benzinga
Macy's, Palo Alto Networks And Other Big Gainers From Tuesday
August 24, 2022
Via
Benzinga
Alcon May Struggle To Meet 2023 Margin Targets With This Latest Acquisition, Says This Analyst
August 23, 2022
Via
Benzinga
Dow Drops Over 100 Points; Aerie Pharmaceuticals Shares Spike Higher
August 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 23, 2022
Via
Benzinga
Stocks Cut Lower As Dow Sheds Another Triple Digits
August 23, 2022
Via
Talk Markets
Nasdaq Turns Lower; Crude Oil Rises Sharply
August 23, 2022
Via
Benzinga
Why Windtree Therapeutics Is Trading Higher By Over 60%, Here Are 61 Stocks Moving In Tuesday's Mid-Day Session
August 23, 2022
Via
Benzinga
Why Is Ocugen (OCGN) Stock Climbing Higher Today?
August 23, 2022
Via
InvestorPlace
Aerie Pharmaceuticals (NASDAQ: AERI) Enters into Agreement to be Acquired by Alcon (NYSE: ALC) for $770 Million
August 23, 2022
Via
Spotlight Growth
INTC Stock Alert: What to Know as Intel Co-Invests in Arizona Chip Factories
August 23, 2022
Via
InvestorPlace
Why Is Aerie Pharmaceuticals (AERI) Stock Up 35% Today?
August 23, 2022
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.